Could cause temporary or reversible harm; serious harm is unlikely.
Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.
| Brand name | ZOLADEX |
| Generic name | GOSERELIN |
| Active ingredient(s) | GOSERELIN ACETATE |
| Distributed by / for | TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com |
| NDC | 70720-950-36 |
| Full product label | Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36. |
| Recalling firm | TerSera Therapeutics LLC |
| Distribution | USA Nationwide |
| Quantity | 296 cartons |
| Recall initiated | 2026-08-31 |
| Report date | 2026-10-07 |
| Recall completed | — |
| Recall number | D-0875-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Deerfield IL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗